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Correspondence 515the superiority of multidetector computed tomography
(MD-CT) versus MRI still exists.
MRI allows swift 3 D high-resolution imaging, neverthe-
less, because of the closed bore design of the magnet and
the need for patient monitoring devices MRI maybe less
adapted than CT for unstable patients.
On the other hand, despite ionizing radiation hazards
and nephrotoxicity of contrast agents, MD-CT optimized the
balance between spatial and temporal resolution and
invasiveness, hence propelling MD-CT to become the most
widely used modality in current practice, thanks to its wide
availability, speed, cost-effectiveness and efficiency.
Imaging of all phases of contrast enhancement has also
become possible using a single bolus of contrast agent, with
delayed scans to visualize the parenchyma and the late
opacification of false lumen. One significant drawback of
MD-CT is a radiation dose, nevertheless, it is possible to
reduce the radiation rate to a minimum by adequate
parameter optimization.
As said by RE Clough, PR Taylor, it is true that move-
ments of the dissected aortic intimal flap through the
cardiac cycle are not clearly visualized without ECG-gating.
On the other hand, CT without ECG-Gating is actually
sufficient for the arch and the descending aorta, allowing
a complete analysis of the thoracic and abdominal aorta in
one single step. Moreover, ECG-gated CTA can accurately
determine aortic distensibility.
In dissection, the selection of the ‘‘correct’’ Stent-graft
dimensions is crucial. In acute dissections, the diameter of
the non-dissected aortic segment immediately proximal to
the entry tear is considered the reference. Inversely, for
chronic dissection (>6 months) the intima becomes fibrotic
and thus cannot expand. In such cases, a tapered stent-
graft may be preferable and the distal diameter is easily
measured, without major aortic variation during the
cardiac phase.
RE Clough, PR Taylor said that ‘‘MRI generated data
will allow the use of shorter endoluminal devices in
patients requiring intervention’’. We don’t believe that
short stent-graft should be used anymore for dissections
in the future. It is well known that false-lumen throm-
bosis distal to the stent-graft, particularly in the distal
descending aorta, is uncommon, longer stent-grafts than
what is needed to simply cover the primary tear is the
trend.
As a whole, considering the excellent accuracy of the
two modalities, the imaging protocols for aortic diseases
should be tailored to answer specific questions, taking into
consideration the accessibility and the local expertise.
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Comment on ‘‘Endovascular Treatment of Profunda
Femoris Artery Obstructive Disease: Nonsense or
Useful Tool in Selected Cases?’’Dear Editor,
We read with great interest the article by Donas et al. on
the role of angioplasty in the treatment of profunda
femoris artery (PFA) obstructive disease.1 We were also
glad and honoured that our own study2 was mentioned in
the Discussion. Our results showed that isolated PFA
angioplasty was insufficient to support wound healing.
Donas et al. felt this to be in contrast with their own
results. Our study was very small, 21 patients were
included. However, the study of Donas et al. is even smaller
with 15 patients.
Donas et al. have also looked at studies reporting results
of surgical profundaplasties. We feel this is a good approach
to the question, but all studies mentioned by Donas et al.
were from the 1990’s or even older, such as the one by
Kalman et al.3 Our own study4 is much more recent and
based on 106 legs operated on consecutively between
January 2000 and December 2003. We therefore feel it
represents modern patient materials better than studies
which were conducted well over two decades ago. In our
study, published with a 3-year follow-up, none of the 16% of
ulcers healed after surgical profundaplasty.
We fully agree that profunda femoris revascularization
e either surgical or interventional e may have a role, but
we feel only in patients without tissue loss. Based on our
own two studies,2,4 we conclude it is not useful for
patients with the combination of critical ischaemia and
tissue loss.References
1 Donas KP, Pitoulias GA, Schwindt A, Schulte S, Camci M,
Schlabach R, et al. Endovascular treatment of profunda femoris
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2 Diehm N, Savolainen H, Mahler F, Schmidli J, Do DD,
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Response to Comment on ‘‘Endovascular Treatment of
Profunda Femoris Artery Obstructive Disease:
Nonsense or Useful Tool in Selected Cases?’’Dear Professor Savolainen,
Thank you very much for your interest concerning our paper
entitled: ‘‘Endovascular Treatment of Profunda Femoris
Artery Obstructive Disease: Nonsense or Useful Tool in
Selected Cases?’’1
Our experience with endovascular revascularization of
the profunda femoris artery (PFA) showed 93.3% healing of
minor foot or digital ischemic ulcerations during a mean
follow-up of 29.2 months, in contrast with the results from
your series with a mean follow-up of 5.5 months. One
possible explanation may be the number and quality of
distal ‘‘run off’’ vessels. The Profunda Popliteal Collateral
Index seems to be an excellent predictor for success of
profunda revascularization pre-interventionally. Addition-
ally, the quality and duration of the adjunctive ‘‘best’’
medical treatment can also play an important role. In spite
of our good results we treated only a small cohort of our
patients (those with technically demanding and hazardous
‘‘open’’ repair of PFA) by endovascular means.
Regarding to your second comment we used as reference
the ‘‘old’’ but good study of Kalman et al.2 to emphasize
that ‘‘open’’ profundoplasty has been proven efficient for
over two decades ago reflecting long-term durability of
surgical procedures.
In our paper we concluded that the revascularization of
PFA by ‘‘open’’ techniques remains the gold standard. PTA
of PFA could be offered in carefully selected patients with
technically demanding ‘‘open’’ repair of PFA with rest pain
or minor tissue loss, as bailout treatment.
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Comment on ‘‘Patients Undergoing Cardiac Surgery
with Asymptomatic Unilateral Carotid Stenoses have
a Low Risk of Perioperative Stroke’’Dear Editor,
Although we have appreciated the meaningful paper of
Baiou et al.,1 we are not fully convinced to exclude every
asymptomatic patient from combined carotid endarterec-
tomy (CEA) and cardiac procedures, particularly in candi-
dates to coronary artery bypass grafting (CABG). We have to
consider that a significative number of candidates to CABG
may present cerebrovascular threatening carotid lesions,
even if they have no previous symptoms. In a study on 68
patients who underwent simultaneous CEA and CABG we
reported an unstable or ulcerated carotid plaques in 23 out
of 42 asymptomatic patients (54.7%).2 Moreover, in our
current clinical practice we observe many vulnerable
carotid plaques (ulceration, intra-plaque hemorrhage with
or without rupture of the intima) on CEA þ CABG patients,
which resulted mostly asymptomatic.
Although the evidence of significant benefits from
prophylactic CEA in asymptomatic CABG patients is
controversial, we should be afraid to neglect carotid artery
stenosis with vulnerable plaque. We have probably to
extend the indication to prophylactic CEA for specific
instances of asymptomatic carotid artery lesions, that can
be considered a significant risk of stroke in short and
midterm period after CABG. We would to stress the
opportunity to include a complete preoperative plaque
characterization in the selection of candidates to CABG
with concomitant asymptomatic carotid artery stenosis
providing the right indication for prophylactic CEA.References
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